Published in Arch Dermatol Res on January 01, 1989
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest (1994) 2.88
Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol (2009) 2.31
Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol (2008) 1.90
Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One (2010) 1.73
Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium. J Immunol (2010) 1.42
Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35
Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med (1995) 1.19
Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells. Clin Exp Immunol (2004) 1.18
Mucosal resident memory CD4 T cells in protection and immunopathology. Front Immunol (2014) 1.11
TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur J Immunol (2011) 1.06
Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA-452 in normal human skin. Arch Dermatol Res (1993) 1.00
Systemic treatment with either cyclosporin A or methotrexate does not influence the T helper 1/T helper 2 balance in psoriatic patients. J Clin Immunol (2004) 1.00
Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res (1994) 0.93
Dermal clusters of mature dendritic cells and T cells are associated with the CCL20/CCR6 chemokine system in chronic psoriasis. J Invest Dermatol (2013) 0.84
Helminth Infection and Commensal Microbiota Drive Early IL-10 Production in the Skin by CD4+ T Cells That Are Functionally Suppressive. PLoS Pathog (2015) 0.78
Imbalance of CD4+CD29+ and CD4+CD45RA+ T-helper cell subsets in peripheral blood of patients with severe atopic dermatitis. Arch Dermatol Res (1993) 0.78
The pathophysiological role of dendritic cell subsets in psoriasis. BMB Rep (2014) 0.78
Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells. Clin Exp Immunol (2000) 0.77
Food sensitivity and the pathogenesis of atopic dermatitis. J R Soc Med (1997) 0.75
Excessive costimulation of CD3-dependent lymphocyte response by extracellular matrix proteins in severe widespread psoriasis. Arch Dermatol Res (1995) 0.75
Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol (2017) 0.75
Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol (1988) 7.37
The isolation and characterization of the human suppressor inducer T cell subset. J Immunol (1985) 6.69
Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today (1989) 5.86
The isolation and characterization of the human helper inducer T cell subset. J Immunol (1985) 5.21
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol (1982) 2.60
T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol (1984) 2.54
Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol (1988) 2.20
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res (1983) 1.45
Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies. J Immunol (1983) 1.33
The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol (1988) 1.32
Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol (1983) 1.31
T cell subsets and Langerhans cells in lichen planus: in situ characterization using monoclonal antibodies. Br J Dermatol (1981) 1.19
The skin immune system Its cellular constituents and their interactions. Immunol Today (2014) 1.01
Subpopulations of mononuclear cells in lesions of psoriasis, lichen planus and discoid lupus erythematosus studied using monoclonal antibodies. Acta Derm Venereol (1982) 1.00
In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol (1985) 0.99
Different in situ distribution patterns of dendritic cells having Langerhans (T6+) and interdigitating (RFD1+) cell immunophenotype in psoriasis, atopic dermatitis, and other inflammatory dermatoses. J Invest Dermatol (1986) 0.98
Nickel-specific T lymphocyte clones derived from allergic nickel-contact dermatitis lesions in man: heterogeneity based on requirement of dendritic antigen-presenting cell subsets. Eur J Immunol (1987) 0.96
Lichen planus and chronic graft-versus-host reaction. In situ identification of immunocompetent cell phenotypes. J Cutan Pathol (1982) 0.96
Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situ. Acta Derm Venereol (1985) 0.95
In situ immunophenotyping of antigen presenting cells and T cell subsets in atopic dermatitis. Clin Exp Dermatol (1986) 0.89
Mononuclear cell patterns in the skin. An immunohistological and morphometrical analysis. Am J Dermatopathol (1988) 0.85
Imbalance in phenotypic expression of T cell subpopulations during different evolutional stages of lichen planus lesions. Acta Derm Venereol (1983) 0.82
Recent advances of ultrastructural immunocytochemistry of epidermal Langerhans cells. Br J Dermatol (1985) 0.80
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 6.03
T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today (1999) 4.49
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol (1990) 3.77
The economic burden of lymphatic filariasis in India. Parasitol Today (2000) 3.15
IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol (1997) 2.67
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol (1993) 2.63
Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol (2000) 2.30
High-level IL-12 production by human dendritic cells requires two signals. Int Immunol (1998) 2.15
Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood (2001) 2.01
Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol (2000) 2.00
Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc (2000) 1.96
Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood (1997) 1.82
The skin immune system: progress in cutaneous biology. Immunol Today (1993) 1.76
Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol (1996) 1.74
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues. J Clin Microbiol (1991) 1.70
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy (1998) 1.66
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis (2003) 1.65
Pathogenesis of atopic eczema. Lancet (1994) 1.65
Human atopen-specific types 1 and 2 T helper cell clones. J Immunol (1991) 1.62
Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol (1990) 1.62
Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol (1990) 1.59
Characterization of cultured tobacco cell lines resistant to ethionine, a methionine analog. Plant Physiol (1984) 1.57
Haematological and coagulation profile in acute falciparum malaria. J Assoc Physicians India (1992) 1.56
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health (2001) 1.56
DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health (2005) 1.54
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health (2000) 1.50
Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res (1983) 1.45
Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hyg (2001) 1.44
IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol (1981) 1.40
Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol (1995) 1.40
[The immune system of the skin]. Ned Tijdschr Geneeskd (1995) 1.38
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35
Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35
Value of butyrylthiocholine assay for identification of cholinesterase variants. J Med Genet (1970) 1.34
The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol (1988) 1.32
IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J Immunol (2000) 1.32
Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy (2005) 1.31
High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol (1991) 1.30
Bancroftian filariasis in Pondicherry, south India: 1. Pre-control epidemiological observations. Epidemiol Infect (1989) 1.29
Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol (1993) 1.28
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect (2000) 1.27
A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage. Ann Trop Med Parasitol (2006) 1.26
Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol (1999) 1.25
A geostatistical analysis of the geographic distribution of lymphatic filariasis prevalence in southern India. Am J Trop Med Hyg (2002) 1.23
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol (1997) 1.20
Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol (1993) 1.19
Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg (1990) 1.18
Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood (1993) 1.17
Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Trop Med Int Health (1999) 1.17
Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis. Ann Trop Med Parasitol (2005) 1.17
Multiple origins of the mtDNA 9-bp deletion in populations of South India. Am J Phys Anthropol (1999) 1.16
Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29/33-kDa doublet proteins on mycobacterial cell wall. Scand J Immunol (1991) 1.15
Functional impairment caused by lymphatic filariasis in rural areas of south India. Trop Med Int Health (1997) 1.14
T-cell receptor gamma delta bearing cells in normal human skin. J Invest Dermatol (1990) 1.13
Immune dysregulation in atopic eczema. Arch Dermatol (1992) 1.13
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol (2001) 1.13
Prevention of running injuries by warm-up, cool-down, and stretching exercises. Am J Sports Med (1993) 1.13
Antigen-presenting cell function of dendritic cells and macrophages in proliferative T cell responses to soluble and particulate antigens. Eur J Immunol (1986) 1.12
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health (2003) 1.11
Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells. J Immunol (1996) 1.11
The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol (1995) 1.11
Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol (1976) 1.10
Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods (1989) 1.10
CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol (1996) 1.10
The mosquito problem and type and costs of personal protection measures used in rural and urban communities in Pondicherry region, South India. Acta Trop (2003) 1.10
Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Trans R Soc Trop Med Hyg (1996) 1.09
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol (1993) 1.08
Bancroftian filariasis in Pondicherry, south India: 2. Epidemiological evaluation of the effect of vector control. Epidemiol Infect (1989) 1.07
Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol (1998) 1.06
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. Infect Immun (1992) 1.06
Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv Exp Med Biol (1997) 1.06
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis (1998) 1.06
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Characterization of dendritic cells, isolated from normal and stimulated lymph nodes of the rat. Cell Tissue Res (1985) 1.05
Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion. Biochem J (1999) 1.04
Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol (1992) 1.04
The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology (1998) 1.04
Diversity and divergence among the tribal populations of India. Ann Hum Genet (2005) 1.04
Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol (1999) 1.03
The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology (2004) 1.03
Control of malaria and filariasis vectors in South India. Parasitol Today (1987) 1.03
The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med (1998) 1.03
Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol (1997) 1.02
Extraosseous Ewing's sarcoma of the kidney. Urol Int (2002) 1.02
Larvicidal & synergestic activity of plant extracts for mosquito control. Indian J Med Res (1985) 1.02